These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12387587)

  • 21. Comparison of coronary risk factors and quality of life in coronary artery disease patients with versus without diabetes mellitus.
    Pischke CR; Weidner G; Elliott-Eller M; Scherwitz L; Merritt-Worden TA; Marlin R; Lipsenthal L; Finkel R; Saunders D; McCormac P; Scheer JM; Collins RE; Guarneri EM; Ornish D
    Am J Cardiol; 2006 May; 97(9):1267-73. PubMed ID: 16635593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl].
    Arteaga A; Martínez A; Pollak F; Borghesi L; Catalán L; Acosta AM; Leighton F
    Rev Med Chil; 1995 Feb; 123(2):145-57. PubMed ID: 7569454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Incidence of dyslipidemia and its relation to coronary artery disease in Brazilian populations].
    da Luz PL; Carvalho ME; Cardoso RH; Gallucci SD; Pileggi F
    Arq Bras Cardiol; 1990 Apr; 54(4):257-64. PubMed ID: 2275627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II.
    McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J
    Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
    Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
    Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulse wave velocity and coronary risk stratification.
    Mendonça MI; Reis RP; Sousa AC; Gomes S; Faria P; Pereira A; Silva B; Serrão M; Santos N; Sousa FS; Silva JA; Sousa J; Ornelas I; Freitas S; Cardoso A; Araújo JJ
    Rev Port Cardiol; 2009 Feb; 28(2):155-71. PubMed ID: 19438151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease.
    Faergeman O; Holme I; Fayyad R; Bhatia S; Grundy SM; Kastelein JJ; LaRosa JC; Larsen ML; Lindahl C; Olsson AG; Tikkanen MJ; Waters DD; Pedersen TR;
    Am J Cardiol; 2009 Aug; 104(4):459-63. PubMed ID: 19660594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
    Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
    Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men (aged < or = 50 years) and women (< or = 60 years) with coronary artery disease.
    Kwiterovich PO; Coresh J; Bachorik PS
    Am J Cardiol; 1993 Mar; 71(8):631-9. PubMed ID: 8447257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and practice assessment of workers in a pharmaceutical company about prevention of coronary artery disease.
    Attarchi M; Mohammadi S; Nojomi M; Labbafinejad Y
    Acta Med Iran; 2012; 50(10):697-703. PubMed ID: 23275286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database).
    Krittanawong C; Daher M; Hahn J; Narasimhan B; Wang Z; Alam M; Jneid H; Virani SS
    Am J Cardiol; 2021 Aug; 153():142-144. PubMed ID: 34172242
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased serum gamma-glutamyltransferase in hypertriglyceridemia: comparison with serum pseudocholinesterase.
    Cucuianu M; Zdrenghea D; Pop M; Opincaru A
    Clin Chim Acta; 1976 Sep; 71(3):419-27. PubMed ID: 9218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Butyrylcholinesterase and diabetes mellitus in the CHE2 C5- and CHE2 C5+ phenotypes.
    Cwiertnia MM; Alcântara VM; Réa RR; Faria AC; Picheth G; Scartezini M; Graef LE; Welter M
    Arq Bras Endocrinol Metabol; 2010 Feb; 54(1):60-7. PubMed ID: 20414550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudocholinesterase in obese and hyperlipemic subjects.
    Cucuianu M; Popescu TA; Haragus S
    Clin Chim Acta; 1968 Oct; 22(2):151-5. PubMed ID: 5687082
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach.
    Sridhar GR; Nirmala G; Apparao A; Madhavi AS; Sreelatha S; Rani JS; Vijayalakshmi P
    Lipids Health Dis; 2005 Sep; 4():18. PubMed ID: 16150144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Butyrylcholinesterase activity and metabolic syndrome in obese patients.
    Alcântara VM; Oliveira LC; Réa RR; Suplicy HL; Chautard-Freire-Maia EA
    Clin Chem Lab Med; 2005; 43(3):285-8. PubMed ID: 15843232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonsense mutation in exon 2 of the butyrylcholinesterase gene: a case of familial cholinesterasemia.
    Hidaka K; Iuchi I; Yamasaki T; Ueda N; Hukano K
    Clin Chim Acta; 1997 May; 261(1):27-34. PubMed ID: 9187502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Butyrylcholinesterase: association with the metabolic syndrome and identification of 2 gene loci affecting activity.
    Valle A; O'Connor DT; Taylor P; Zhu G; Montgomery GW; Slagboom PE; Martin NG; Whitfield JB
    Clin Chem; 2006 Jun; 52(6):1014-20. PubMed ID: 16574762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.